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Purpose. We sought to determine the prevalence of clinically signiﬁcant non-cardiac abnormalities found in pediatric and adult
patients undergoing cardiac magnetic resonance imaging (CMRI), and understand the impact of age on it’s occurrence. Methods.
WeretrospectivelyreviewedallpatientsundergoingCMRIbetweenMay2004andJuly2007.Findingswereconsideredsigniﬁcantif
they required radiographic or clinical follow-up. Results. A total of 408 patients underwent CMRI during the study period. Twenty
two (16%) pediatric patients (age < 19 years, n = 135) were found to have a total of 22 non- cardiac abnormalities, 3 of which
were clinically signiﬁcant. Sixty four (23%) adult patients (age > 19 years, n = 273) were found to have a total of 77 non-cardiac
abnormalities, 33 of which were clinically signiﬁcant. The prevalence of clinically signiﬁcant non-cardiac abnormalities was 2%
in the pediatric cohort and 11% in the adult cohort (P = 0.05). Within the adult population, the prevalence of signiﬁcant non-
cardiac abnormalities increased with advancing age (P = 0.05). Conclusions. In a population of unselected patients undergoing
CMRI,unanticipatednoncardiacabnormalitieswerefrequentlyseen.Asmallnumberoftheseweresigniﬁcant,withtheprevalence
increasing with age.
1.Introduction
CMRI is an evolving technology for noninvasive imaging
of the heart, pericardium, and great vessels with increasing
application in clinical cardiology. The high temporal and
spatial resolution of CMRI aﬀords versatility and potential
superiority over other modalities for imaging patients with
complexcongenitalheartdisease,cardiomyopathies,andval-
vular pathology [1, 2]. Currently, as recognized by the
American College of Cardiology Foundation, there are sev-
enteenindicationsconsideredappropriateforCMRI,divided
into the three broad categories consisting of coronary artery
disease, cardiac structure and function, and myocardial
viability [3]. As utilization of CMRI accelerates, so does
the probability of detecting noncardiac abnormalities within
the thorax, mediastinum, and abdomen, in part because
of the expanded ﬁeld of view aﬀorded. Currently, little is
known of the prevalence of noncardiac abnormalities found
in patients of varying ages undergoing CMRI with three
studies suggesting a prevalence of between 7.6% and 43%
[4–6]. Therefore, we sought to determine the prevalence
of clinically signiﬁcant noncardiac abnormalities found in
patients undergoing CMRI by performing a retrospective
review of all CMRI studies performed in pediatric and adult
patients at our institution between July 2004 and July 2007.
2. Methods
2.1. Patient Population. The study group consisted of all pa-
tients who underwent cardiac magnetic resonance imaging
at Maine Medical Center (Portland, ME) between July 2004
and July 2007. Patients were primarily referred for CMRI by
either a pediatric cardiologist or their primary adult car-
diologist, with the majority of patients being ambulatory
at the time of their CMRI. Reports were retrospectively
reviewed, with all abnormalities involving noncardiac struc-
tures identiﬁed and categorized according to organ system2 The Scientiﬁc World Journal
and clinical signiﬁcance. Abnormal noncardiac ﬁndings
involved structures other than the heart, pericardium, and
great vessels and were included in the study if they were
unknownorunanticipatedbythereadersatthetimeofinter-
pretation. Noncardiac ﬁndings were considered signiﬁcant
if additional radiographic imaging was advised or if further
clinical investigation was warranted [5]. Recommendations
by the readers for additional radiographic followup adhered
to practice guidelines; examples included followup for medi-
astinal lymphadenopathy (LAd) greater than 1 centimeter,
masses (e.g., other than simple cysts), pleural eﬀusions, and
vertebral abnormalities. Followup of patients with clinically
signiﬁcant noncardiac abnormalities was veriﬁed by review-
ingradiographicstudiesandmedicalrecordsavailablewithin
our institution. Because of the potential diﬀerences in indi-
cationsforCMRI,aswellasage-relateddiﬀerencesincomor-
bidities, the study population was divided into a pediatric
cohort (age ≤ 19 years) and an adult cohort (age ≥ 19 years).
Institutional review board approval was obtained prior to
initiation of the study.
2.2. Data Acquisition. Images were obtained on a 1.5 Tesla
GE (GE Healthcare, Milwaukee, Wis) magnetic resonance
scanner using a cardiac 8-element phased-array coil and
dedicated cardiac software. Standardized imaging protocols
included black blood double inversion recovery sequences
(DIRV), steady state free precession (SSFP) and fast gradient
echo images, phase velocity ﬂow mapping, magnetic reso-
nance angiography, and postgadolinium myocardial delayed
enhancement.Imagingprotocolsweredeterminedbyclinical
indication and reviewed by the interpreting physician at the
time of acquisition. Axial imaging was performed to include
the entire chest from aortic arch to below the diaphragm
using a single-phase SSFP localizer scan and a DIRV se-
quence, with cine sequences performed with smaller FOV’s
centered on the heart frequently tailored to the speciﬁc clin-
ical question. All studies were jointly interpreted by a cardi-
ologist (AMM) and a radiologist (ABL), with the creation of
a single report which was stored in an electronic database,
PACS Web1000 (AGFA, Mortsel, Belgium).
2.3.StatisticalAnalysis. Todeterminewhethertheprevalence
ofnoncardiacﬁndingsdiﬀeredwithage,wedividedtheadult
cohort into age blocks of twenty years. Comparisons were
made between the pediatric and adult cohorts, as well as
between each of the adult age blocks. Due to the small num-
ber of patients in the age block of 80 years and older, this age
block was not included in the analysis. Age category com-
parative analysis was conducted with the χ2 test for indepen-
dence, using one degree of freedom at the P = 0.05 level
of signiﬁcance. Fischer’s exact test was not required as the
expected frequencies were greater than 5 for each of the
comparisons made.
3. Results
3.1. Demographics. A total of 408 consecutive patients un-
derwent CMRI at our institution during the study period.
The study group was comprised of 210 males and 198 fe-
males, with a median age of 30 years (range 6 weeks to 85
years). There were 135 patients in the pediatric cohort, with
a median age of 14 years (range 6 weeks to 19 years). Within
this cohort, the most common clinical indication for CMRI
was complex congenital heart disease (38%), followed by
evaluation for arrhythmogenic right ventricular dysplasia
(ARVD) (21%) and aortic disease, including aortic valve pa-
thology (17%). In the adult cohort, there were a total of 273
patients, with a median age of 45 years (range, 20–85 yrs).
The most common clinical indication for CMRI in the adult
cohortwasevaluationforARVD(31%),followedbycomplex
congenital heart disease (25%) and cardiomyopathy (13%)
(Table 1).
3.2. Pediatric Cohort. Twenty-two of the 135 patients (16%)
were found to have a total of 22 noncardiac abnormalities.
Three of these 22 noncardiac abnormalities (14%) were con-
sidered clinically signiﬁcant. There was no dominant cate-
gory of clinically signiﬁcant abnormality nor was one organ
systemmorelikelytohaveaclinicallysigniﬁcantabnormality
than another. Overall, 2% of the pediatric cohort was found
to have clinically signiﬁcant noncardiac abnormalities on
CMRI (Table 2).
Organ system involvement of the noncardiac abnormali-
ties is depicted in Figure 1(a). The three clinically signiﬁcant
noncardiac abnormalities consisted of para-aortic LAd >
1cm, suspected azygous lobe of the right lung and syrin-
gomyelia. The patient with para-aortic LAd had a history of
non-Hodgkin’s lymphoma; comparison of the CMRI with a
computed tomography (CT) obtained three months earlier
showed stability of the LAd. Long-term radiographic fol-
lowup was recommended to monitor recurrence of disease.
One patient had a low-intensity signal adjacent to the tra-
chea and superior vena cava (SVC), and a chest X-ray was
recommended to determine if this abnormality was an azy-
gous lobe of the right lung. The patient with suspected syrin-
gomyelia underwent magnetic resonance imaging (MRI) of
the thoracic and lumber spine two months later, conﬁrming
the diagnosis. There was no evidence of spinal cord compro-
mise, and the patient had an additional MRI six months later
for continued monitoring.
Among the noncardiac abnormalities not requiring fol-
lowup,pulmonaryﬁndingscomprisedthelargestgroup(n =
15), representing 68% of all noncardiac abnormalities. Ten
of the pulmonary abnormalities were in patients who were
intubated at the time of CMRI acquisition and included
atelectasis (n = 6), pleural eﬀusions (n = 2), consolidation
(n = 1), and a collapsed lung (n = 1). No followup was rec-
ommended for these 10 ﬁndings. The remaining noncardiac
abnormalities not requiring followup were airway narrowing
without evidence of mass eﬀect (n = 4), scoliosis (n = 4),
and subcentimeter mediastinal LAd (n = 1).
3.3. Adult Cohort. Sixty-four of the 273 patients (23%)
were found to have a total of 77 noncardiac abnormalities.
Thirty-three of these 77 noncardiac abnormalities (43%)
wereconsideredclinicallysigniﬁcant.WhileLAd,pulmonaryThe Scientiﬁc World Journal 3
Table 1: Study population.
Pediatric (%) Adult (%)
Demographics
n 135 273
Male 79 (59) 131 (48)
Female 56 (41) 142 (52)
Median age, years (range) 14 (6wks-19) 45 (20–85)
Study indication
Aortic valve and arch 23 (17) 29 (11)
ARVD 29 (21) 86 (31)
Cardiomyopathy 12 (9) 35 (13)
Congenital∗ 51 (38) 68 (25)
Pericardial 1 (1) 8 (3)
Valvular 14 (10) 29 (11)
Miscellaneous 5 (4) 18 (6)
∗Excluding isolated aortic valve disease.
Table 2: Comparison of noncardiac ﬁndings in pediatric and adult cohorts.
Pediatric Adult
Number of patients Percent of population Number of patients Percent of population
22 16 All 64 23
32 ∗ Signiﬁcant 30 11
∗The diﬀerence in prevalence of signiﬁcant noncardiac ﬁndings in the pediatric and adult cohorts was statistically signiﬁcant (P<0.05 using the χ2 test for
independence).
abnormalities, and abdominal abnormalities were relatively
equal in comprising the overall number of noncardiac ab-
normalities, pulmonary abnormalities represented nearly
half of the clinically signiﬁcant ﬁndings. Overall, 11% of the
adult cohort was found to have clinically signiﬁcant noncar-
diac abnormalities on CMRI (Table 2).
Organ system involvement of the noncardiac abnormal-
ities is depicted in Figure 1(b). Clinically signiﬁcant pul-
monary abnormalities included pleural eﬀusions (n = 13)
and lung masses (n = 2). All of the patients with pleural
eﬀusions had been hospitalized prior to the CMRI and had
radiographic and clinical followup for the persistence of the
eﬀusions. Two of the patients with pleural eﬀusions under-
went diagnostic thoracentesis as part of their clinical fol-
lowup, and all thirteen patients were eventually diagnosed
with decompensated heart failure. The two patients with
lung masses had prior diagnoses relevant to these ﬁndings:
one patient had a prior history of nonsmall cell lung cancer
while the other patient was known to have sarcoidosis.
Though the clinical diagnosis for each patient was docu-
mented in the medical record, the readers had to compare
the CMRI to prior ﬁlms, and serial radiographic studies were
suggested for each of the patients. Pulmonary ﬁndings not
requiring followup included airway narrowing without evi-
dence of mass eﬀect (n = 3), pulmonary hypoplasia (n = 2),
atelectasis (n = 2), and pneumonectomy in a patient with a
history of mediastinal teratoma resection.
There were twenty patients with 21 abdominal abnor-
malities, 16 of which were either renal or hepatic masses.
Nine of the abdominal ﬁndings (43%) were clinically signi-
ﬁcant. Six of the hepatic lesions (75%) and two of the renal
lesions (25%) required additional imaging to exclude malig-
nancy or to determine if the ﬁnding was a simple cyst. The
remaining clinically signiﬁcant abdominal abnormality in-
volved one patient, whose liver on T1-weighted imaging
appeared lower intensity than spleen and muscle, raising the
suspicion of hemochromatosis; additional investigation was
recommended. None of the seven patients with the clinically
signiﬁcant abdominal masses was diagnosed with a malig-
nancy. Abdominal ﬁndings not requiring followup included
ascites in a patient with known cirrhosis, hiatal hernias
(n = 2), and an accessory spleen. The category of abdominal
abnormalities was the only one in which there was a differ-
ence among readers’ interpretations; for two patients, the
radiologist amended the report to clarify the identity of the
noncardiac abnormality.
There were 19 patients with LAd, though only 5 (20%)
patients had LAd >1cm requiring additional radiographic
followup (Table 2). Among the ﬁve patients, one had surveil-
lance imaging for greater than one year while another had
mediastinoscopywithbiopsytoexcludemalignancy.Noneof
these patients were found to have malignancies. Granuloma-
tous disease was the most common ﬁnal diagnosis (n = 2).
The incidence of clinically signiﬁcant vertebral abnor-
malities was 25% (n = 3), similar to that of clinically sig-
niﬁcant LAd. One patient was thought to have an expansile
lesion, one was found to have a lytic lesion of thoracic verte-
bra 12, and one patient had severe degenerative disc disease4 The Scientiﬁc World Journal
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Figure 1: Organ involvement of noncardiac ﬁndings in the pediatric and adults cohorts.
with herniation and suspected of cord compression. Verte-
bral abnormalities not requiring followup included scoliosis
(n = 6),vertebralhemangiomas(n = 3),andseveredegener-
ative changes of the spine (n = 1).
The two miscellaneous noncardiac abnormalities were
comprised of a patient with bilateral breast implants and one
patient with a thyroid mass. The patient with the thyroid
mass underwent further imaging and was diagnosed with a
calciﬁed cyst.
Comparing the pediatric and adult cohorts, the preva-
lence of signiﬁcant noncardiac ﬁndings was statistically sig-
niﬁcant (2% versus 11%, P = 0.05). This ﬁnding was due to
the increasing prevalence of signiﬁcant noncardiac ﬁndings
in patients older than forty years of age (Figure 2).
4. Discussion
Our study is the ﬁrst to report the prevalence of noncardiac
abnormalities in a series of unselected consecutive patients
across a broad age range undergoing CMRI at a single in-
stitution. We retrospectively reviewed 408 patients who un-
derwent CMRI, dividing the study population into pediatric
and adult cohorts based on age. Within the pediatric cohort,
16% of the patients were found to have noncardiac abnor-
malities, with 14% of these abnormalities considered clin-
ically signiﬁcant and requiring additional followup. In the
adult cohort, 23% of patients were found to have noncardiac
abnormalities, with 43% of the ﬁndings considered clinically
signiﬁcant. Overall, 2% of the pediatric cohort and 11%
of the adult cohort had noncardiac abnormalities found
on CMRI that were considered clinically signiﬁcant. To our
knowledge, this is the ﬁrst to report such ﬁndings in both
pediatric and adult patients and determine the impact of
increasing age on prevalence of noncardiac ﬁndings.
We divided the study population into pediatric and adult
cohorts given the unselected population, the diﬀerences in
CMRI indication, and the greater potential for comorbiditiesThe Scientiﬁc World Journal 5
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Figure 2: Prevalence of noncardiac ﬁndings by age within adult cohort. The diﬀerence in the percent of signiﬁcant noncardiac ﬁndings
between these age groups was statistically signiﬁcant (P<0.05 using the χ2 test for independence). The age group greater than 80 years of
age was comprised of one patient with a noncardiac ﬁnding which was not signiﬁcant. This age group was not included in our analysis due
to the small sample size.
commonly seen with advancing age. Pediatric patients were
more likely to undergo CMRI for complex congenital heart
disease and evaluation of the aortic valve and arch, while
adultpatientsweremorelikelytobeevaluatedforARVDand
myocardial scar. In the pediatric cohort, pulmonary abnor-
malities comprised two-thirds of total noncardiac ﬁndings.
In the adult cohort, LAd, pulmonary, and abdominal abnor-
malitieswereapproximatelyequalinnumberandcollectively
represented 83% of all noncardiac ﬁndings. There was a
marked variety in the breath of noncardiac ﬁndings detected
by CMRI, with clinically signiﬁcant abnormalities ranging
from pleural eﬀusions, LAd, and abdominal masses to syrin-
gomyelia,vertebrallesions,possiblespinalcordcompression,
and a thyroid mass. Although 39 patients (2 pediatric, 37
adults) had either LAd or a mass detected on CMRI, no new
malignancies were diagnosed in the study population.
To date no study has assessed the prevalence of noncar-
diac ﬁndings across a broad pediatric and adult age range.
Chan et al. [4] reported on 1534 patients (average age 50
years) performed at an academic center over a 5-year period.
They found 7.6% of studies with noncardiac ﬁndings con-
sisting of major ﬁndings in 3.4% (adenopathy, lung abnor-
malities, and mediastinal masses) and 4.6% with minor ab-
normalities.Theynotedthatthemajority(62%)ofthemajor
ﬁndings were previously known, with only 0.4% of the ﬁnd-
ings deemed new and clinically important. They found that
the average age was higher in those with associated noncar-
diac ﬁndings. Dewey et al. studied 108 adult patients with
suspected coronary artery disease (CAD) who underwent
CMRI and CCTA prior to diagnostic cardiac catheterization,
comparing the rate of signiﬁcant and insignificant noncar-
diac ﬁndings for both of the noninvasive imaging modalities
[5]. Imaging protocols were based on the intended objective
of evaluating the patients for CAD. A total of 16 noncardiac
ﬁndings (15%) were detected by CCTA, of which ﬁve were
considered signiﬁcant. These ﬁve abnormalities consisted of
pulmonary embolism, pleural eﬀusions, sarcoidosis, a pul-
monary nodule, and a hiatal hernia. CMRI detected nine
noncardiac abnormalities (8%); only two of the ﬁndings
(pleural eﬀusions and sarcoidosis) were considered signiﬁ-
cant. Overall, 5% and 2% of patients were found to have
clinically signiﬁcant noncardiac abnormalities by CCTA and
CMRI, respectively. More recently, Atalay et al. [6]r e p o r t e d
on 240 CMRI examinations that included 8 pediatric
patients. They reported a rate of 43% with noncardiac ﬁnd-
ings with a higher occurrence in older patients (>60 years)
(43% versus 17%). The distribution of ﬁndings was 29% in
the abdomen, 70% in the chest, and 1% in the neck. Of note,
in their study, ﬁve new cases of cancer were diagnosed. This
regional distribution of noncardiac ﬁndings was similar to
our adult subgroup (0.03% neck, 70% chest, and 27% abdo-
men).
Recognizing the prevalence of noncardiac abnormalities
on cardiac imaging studies is important for the ordering
and interpreting physicians, as well as for the patient. This
is particularly relevant at a time when clinical utilization of
CMRI and CCTA is increasing. Comparing the prevalence
of noncardiac ﬁndings on CMRI and CCTA is a reasonable
endeavor, given that both modalities oﬀer high spatial and
temporal resolution, are diagnostic, and have the ability to
detect abnormalities within an expanded FOV. Substantially
more data is available regarding the prevalence of noncardiac
abnormalities detected by CCTA [5, 7–13], which ranges
from 11% to 67% of patients (Table 3) .T h eb r o a dr a n g ei n
prevalence of noncardiac abnormalities most likely reﬂects
the diﬀerences in imaging protocols, deﬁnitions of noncar-
diac ﬁndings, and the diﬀerences in FOV used in the CCTA
studies.
CCTA utilizes a small FOV in order to maximize voxel
resolution while minimizing radiation exposure of the pa-
tient. Reduction in the number of slices along the z-axis
ensures that only a portion of the lung parenchyma will be
visualized. While complete data in the x-y direction is ob-
tained, this expanded FOV is not used in analyzing the coro-
nary arteries and is excluded without additional reconstruc-
tions. The restricted FOV typical of CCTA includes roughly6 The Scientiﬁc World Journal
Table 3: CCT studies examining noncardiac ﬁndings.
Reference Year Indication for CCT n (Male/Female) Mean age (yrs) Noncardiac
ﬁndings (%)
Signiﬁcant noncardiac
ﬁndings (%)
Haller et al. [8] 2005 Suspected CAD 166 (123/43) 64 36 (21.6) 18 (10.8)
Onuma et al. [12] 2006 Suspected CAD 503 (382/121) 66 ± 10 346 (58.1) 114 (22.7)
Dewey et al. [5] 2007 Suspected CAD 108 (80/28) 63 ± 9 11 (10.1) 5 (4.6)
Gil et al. [7] 2007 Asymptomatic,
Self-referred 258 (202/56) 54 ± 8 151 (56.2) 40 (15.5)∗
Kirsch et al. [9] 2007 Suspected CAD 100 (68/32) 63 ± 15 67 (67) 25 (25)∗
Mueller et al. [11] 2007 Post-operative
CABG 259 (190/69) 61 ± 27 34 (13.1) 26 (10)∗
Law et al. [10] 2008 Suspected CAD 295 (198/97) 56 51 (17.2) 46 (15.6)∗
MacHaalany et al. [13] 2009 Suspected CAD 966 (535/431) 58 ± 16 401 (41.5) 80 (20)
∗Using our deﬁnition of signiﬁcant noncardiac ﬁnding.
10% of lung tissue [14]. In a study comparing the restricted
and expanded FOVs aﬀorded by CCTA with those obtained
by noncardiac chest CT, Haller et al. demonstrated that
the restricted CCTA FOV includes 35.5% of the total chest
volume while the maximum expanded CCTA FOV includes
only 70.3% of total chest volume [8]. Though the complete
thorax is imaged on CMRI, visualization of structures de-
pends upon the sequences used: adenopathy is best apprecia-
ted on T1 (nonfat saturated) sequences while cysts are best
seen on T2 and postgadolinium T1 sequences. Both modal-
ities allow manipulation of the acquired data and FOV, with
the imaging sequences determined principally by the clinical
question and partly by the physician’s tolerance for detecting
unintended or unwanted noncardiac abnormalities. Cur-
rently, there are no standardized protocols for either modal-
ityaddressingtheissueofimagingsequencesandsizeofFOV.
There is, however, a medicolegal and medicomoral obliga-
tion, with the interpreting physician responsible to the pa-
tient for all of the information available on the examina-
tion [15]. Performing additional reconstructions using an
expanded FOV (CCTA) or including additional sequences
(CMRI),whilenottheinitialpurposeofeithermodality,may
be most consistent with the ethical principle of beneﬁcence
[16, 17].
Detection of signiﬁcant noncardiac abnormalities with
either CMRI or CCTA potentially impacts patient care. CT is
superior for imaging lung parenchyma, and much has been
written about the detection of lung abnormalities by CCTA,
principally lung nodules and masses [14]. The results of our
study extend this discussion beyond the exclusion of malig-
nancy to include diverse ﬁndings such as syringomyelia,
hemochromatosis, and spinal cord compression, all of which
can have an important impact on a patient’s health. While
the absolute number of patients with signiﬁcant noncardiac
abnormalities and the type of abnormalities varies (due to
diﬀerences in patient population, clinical indication, and
technique), current data suggest that noncardiac abnormal-
ities detected by either modality are consequential both in
numbers and potential clinical consequence. The spectrum
of abnormalities found in our study emphasizes the need
for physicians to be methodical and thorough in their inter-
pretive approach, as well as competent in the analysis of the
entire data set, and not just the cardiac structures and func-
tion. Furthermore, vigilance for probable noncardiac ﬁnd-
i n g si sn e c e s s a r y .
Our study is limited by the incomplete followup data of
our patient population. While each patient’s record within
our institution was reviewed, seven adult patients and one
pediatricpatientwithaclinicallysigniﬁcantnoncardiacﬁnd-
ing did not have followup studies within our EMR/PACs,
and therefore the clinical impact of the noncardiac abnor-
malities is not fully known. Two patients were still receiving
continuedmonitoringofthenoncardiacabnormalitiesatthe
end of the study, and therefore a ﬁnal diagnosis is not yet
known. The intent of our study was to report the prevalence
of noncardiac ﬁndings on CMRI and not focus on long-
term followup. Our institution does not perform cardiac
perfusion or viability studies with CMRI, which may select
out a certain segment of patients appropriate for CMRI. We
did not attempt to address the potential economic impact
of the noncardiac ﬁndings or comment on the nature of the
recommended followup.
In conclusion, CMRI is a powerful and versatile nonin-
vasive imaging modality with increasing clinical utilization
for the evaluation of patients with known or suspected CAD,
structural heart disease including complex congenital dis-
ease, and myocardial viability. The expanded ﬁeld of view
anddiagnosticqualityoftheimagesaﬀordstheprobabilityof
detecting a wide variety of unanticipated noncardiac abnor-
malities, the likelihood of which increases with age. There-
fore, studies should be interpreted in a thorough and me-
thodical fashion by competent physicians who are appropri-
ately trained, to ensure that all imaged structures are appro-
priately evaluated. Collaboration between cardiology and
radiology is advisable to ensure all structures are adequately
evaluated.
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